April 19 (SeeNews) - Serbia plans to invest 100 million euro ($120 million) in equipment that will enable the country to start the production of a tetravalent flu vaccine at the Torlak vaccine institute in Belgrade, Serbian president Aleksandar Vucic said.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
